Isaxonine

CHEMBL1740513 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

137.2 g/mol

LogP

1.3

Phase

4

This neurotropic compound was investigated for its potential to support nerve regeneration and treat peripheral neuropathy, with some early research suggesting it could promote the survival of damaged neurons. It was not widely adopted in clinical practice.

Masse moléculaire

137,1800 g/mol

LogP

1,30

TPSA

37,80 Å²

Règle des 5 de Lipinski

Conforme

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(C)Nc1ncccn1

InChI

InChI=1S/C7H11N3/c1-6(2)10-7-8-4-3-5-9-7/h3-6H,1-2H3,(H,8,9,10)

Molecular Formula

C7H11N3

HBD / HBA

1 / 3

Liaisons Rotatives

2

Atomes Lourds

10

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This neurotropic compound was investigated for its potential to support nerve regeneration and treat peripheral neuropathy, with some early research suggesting it could promote the survival of damaged neurons. It was not widely adopted in clinical practice.

Yes, Isaxonine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1740513. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 71169. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Isaxonine sur PillFYI

Structure

Données Clés

Formule: C7H11N3

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.